Jakub Lagan1, Josephine H Naish2, Kara Simpson3, Min Zi2, Elizabeth J Cartwright2, Phil Foden4, Julie Morris4, David Clark4, Lindsay Birchall3, Jessica Caldwell2, Andrew Trafford2, Christien Fortune1, Michael Cullen4, Nazia Chaudhuri5, James Fildes6, Jaydeep Sarma1, Erik B Schelbert7, Matthias Schmitt1, Karen Piper Hanley8, Christopher A Miller9. 1. Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom; Division of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom. 2. Division of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom. 3. Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, United Kingdom. 4. Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom. 5. Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom; Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, United Kingdom. 6. Manchester Collaborative Centre for Inflammation Research, University of Manchester, Manchester, United Kingdom; The Transplant Centre, Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom. 7. Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA; UPMC Cardiovascular Magnetic Resonance Center, Heart and Vascular Institute, Pittsburgh, Pennsylvania, USA; Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsylvania. 8. Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, United Kingdom; Wellcome Centre for Cell-Matrix Research, University of Manchester, Manchester, United Kingdom. 9. Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom; Division of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom; Wellcome Centre for Cell-Matrix Research, University of Manchester, Manchester, United Kingdom. Electronic address: Christopher.Miller@manchester.ac.uk.
Abstract
OBJECTIVES: The purpose of this study was to identify where ultrasmall superparamagnetic particles of iron oxide (USPIO) locate to in myocardium, develop a methodology that differentiates active macrophage uptake of USPIO from passive tissue distribution; and investigate myocardial inflammation in cardiovascular diseases. BACKGROUND: Myocardial inflammation is hypothesized to be a key pathophysiological mechanism of heart failure (HF), but human evidence is limited, partly because evaluation is challenging. USPIO-magnetic resonance imaging (MRI) potentially allows specific identification of myocardial inflammation but it remains unclear what the USPIO-MRI signal represents. METHODS: Histological validation was performed using a murine acute myocardial infarction (MI) model. A multiparametric, multi-time-point MRI methodology was developed, which was applied in patients with acute MI (n = 12), chronic ischemic cardiomyopathy (n = 7), myocarditis (n = 6), dilated cardiomyopathy (n = 5), and chronic sarcoidosis (n = 5). RESULTS: USPIO were identified in myocardial macrophages and myocardial interstitium. R1 time-course reflected passive interstitial distribution whereas multi-time-point R2* was also sensitive to active macrophage uptake. R2*/R1 ratio provided a quantitative measurement of myocardial macrophage infiltration. R2* behavior and R2*/R1 ratio were higher in infarcted (p = 0.001) and remote (p = 0.033) myocardium in acute MI and in chronic ischemic cardiomyopathy (infarct: p = 0.008; remote p = 0.010), and were borderline higher in DCM (p = 0.096), in comparison to healthy controls, but were no different in myocarditis or sarcoidosis. An R2*/R1 threshold of 25 had a sensitivity and specificity of 90% and 83%, respectively, for detecting active USPIO uptake. CONCLUSIONS: USPIO are phagocytized by cardiac macrophages but are also passively present in myocardial interstitium. A multiparametric multi-time-point MRI methodology specifically identifies active myocardial macrophage infiltration. Persistent active macrophage infiltration is present in infarcted and remote myocardium in chronic ischemic cardiomyopathy, providing a substrate for HF.
OBJECTIVES: The purpose of this study was to identify where ultrasmall superparamagnetic particles of iron oxide (USPIO) locate to in myocardium, develop a methodology that differentiates active macrophage uptake of USPIO from passive tissue distribution; and investigate myocardial inflammation in cardiovascular diseases. BACKGROUND: Myocardial inflammation is hypothesized to be a key pathophysiological mechanism of heart failure (HF), but human evidence is limited, partly because evaluation is challenging. USPIO-magnetic resonance imaging (MRI) potentially allows specific identification of myocardial inflammation but it remains unclear what the USPIO-MRI signal represents. METHODS: Histological validation was performed using a murine acute myocardial infarction (MI) model. A multiparametric, multi-time-point MRI methodology was developed, which was applied in patients with acute MI (n = 12), chronic ischemic cardiomyopathy (n = 7), myocarditis (n = 6), dilated cardiomyopathy (n = 5), and chronic sarcoidosis (n = 5). RESULTS: USPIO were identified in myocardial macrophages and myocardial interstitium. R1 time-course reflected passive interstitial distribution whereas multi-time-point R2* was also sensitive to active macrophage uptake. R2*/R1 ratio provided a quantitative measurement of myocardial macrophage infiltration. R2* behavior and R2*/R1 ratio were higher in infarcted (p = 0.001) and remote (p = 0.033) myocardium in acute MI and in chronic ischemic cardiomyopathy (infarct: p = 0.008; remote p = 0.010), and were borderline higher in DCM (p = 0.096), in comparison to healthy controls, but were no different in myocarditis or sarcoidosis. An R2*/R1 threshold of 25 had a sensitivity and specificity of 90% and 83%, respectively, for detecting active USPIO uptake. CONCLUSIONS: USPIO are phagocytized by cardiac macrophages but are also passively present in myocardial interstitium. A multiparametric multi-time-point MRI methodology specifically identifies active myocardial macrophage infiltration. Persistent active macrophage infiltration is present in infarcted and remote myocardium in chronic ischemic cardiomyopathy, providing a substrate for HF.
Authors: Shirjel R Alam; Anoop S V Shah; Jennifer Richards; Ninian N Lang; Gareth Barnes; Nikhil Joshi; Tom MacGillivray; Graham McKillop; Saeed Mirsadraee; John Payne; Keith A A Fox; Peter Henriksen; David E Newby; Scott I K Semple Journal: Circ Cardiovasc Imaging Date: 2012-08-08 Impact factor: 7.792
Authors: Julia Anna Lurz; Christian Luecke; David Lang; Christian Besler; Karl-Philipp Rommel; Karin Klingel; Reinhard Kandolf; Volker Adams; Katharina Schöne; Gerhard Hindricks; Gerhard Schuler; Axel Linke; Holger Thiele; Matthias Gutberlet; Philipp Lurz Journal: JACC Cardiovasc Imaging Date: 2017-04-12
Authors: Martin Ugander; Paul S Bagi; Abiola J Oki; Billy Chen; Li-Yueh Hsu; Anthony H Aletras; Saurabh Shah; Andreas Greiser; Peter Kellman; Andrew E Arai Journal: JACC Cardiovasc Imaging Date: 2012-06
Authors: Colin G Stirrat; Shirjel R Alam; Thomas J MacGillivray; Calum D Gray; Marc R Dweck; Jennifer Raftis; William Sa Jenkins; William A Wallace; Renzo Pessotto; Kelvin Hh Lim; Saeed Mirsadraee; Peter A Henriksen; Scott Ik Semple; David E Newby Journal: Heart Date: 2017-06-22 Impact factor: 5.994
Authors: Christopher A Miller; Josephine H Naish; Paul Bishop; Glyn Coutts; David Clark; Sha Zhao; Simon G Ray; Nizar Yonan; Simon G Williams; Andrew S Flett; James C Moon; Andreas Greiser; Geoffrey J M Parker; Matthias Schmitt Journal: Circ Cardiovasc Imaging Date: 2013-04-03 Impact factor: 7.792
Authors: Stefan Frantz; Ines Falcao-Pires; Jean-Luc Balligand; Johann Bauersachs; Dirk Brutsaert; Michele Ciccarelli; Dana Dawson; Leon J de Windt; Mauro Giacca; Nazha Hamdani; Denise Hilfiker-Kleiner; Emilio Hirsch; Adelino Leite-Moreira; Manuel Mayr; Thomas Thum; Carlo G Tocchetti; Jolanda van der Velden; Gilda Varricchi; Stephane Heymans Journal: Eur J Heart Fail Date: 2018-01-15 Impact factor: 15.534
Authors: Colin G Stirrat; Shirjel R Alam; Thomas J MacGillivray; Calum D Gray; Marc R Dweck; Kevin Dibb; Nick Spath; John R Payne; Sanjay K Prasad; Roy S Gardner; Saeed Mirsadraee; Peter A Henriksen; Scott Ik Semple; David E Newby Journal: Heart Date: 2017-10-06 Impact factor: 7.365
Authors: Jakub Lagan; Erik B Schelbert; Josephine H Naish; Jørgen Vestbo; Christien Fortune; Joshua Bradley; John Belcher; Edward Hearne; Foluwakemi Ogunyemi; Richard Timoney; Daniel Prescott; Hamish D C Bain; Tasneem Bangi; Mahvash Zaman; Christopher Wong; Anthony Ashworth; Helen Thorpe; Robin Egdell; Jerome McIntosh; Bruce R Irwin; David Clark; Graham Devereux; Jennifer K Quint; Richard Barraclough; Matthias Schmitt; Christopher A Miller Journal: JACC Cardiovasc Imaging Date: 2021-05-19